Clinical Features

Management and Current Treatment of Parkinson’s Disease

Parkinson's Disease is a progressive neurological condition. It is the second most common neurodegenerative disease after Alzheimer’s Disease

Parkinson's Disease is a progressive neurological condition. It is the second most common neurodegenerative disease after Alzheimer’s Disease

Parkinson’s Disease is a progressive neurological condition. It is the second most common neurodegenerative disease after Alzheimer’s Disease. However, experts believe we are facing a Parkinson’s Pandemic due to an ageing population, improvements in diagnosis, and advancements in research. Parkinson’s is the fastest-growing neurodegenerative disorder.1

In 2020 experts estimated that globally 9.4 million people are living with Parkinson’s Disease (PD). Experts believe the prevalence of Parkinson’s has double in the last 25 years. The rise in PD prevalence calls for attention to the increasing individual and societal burden and the pressing need for measures to address and impact this challenging disease.2

For verified healthcare professionals

Log in or register for free to read this article. HPN is for healthcare professionals, so new accounts are verified by our team.

Register for free Log in

Join the conversation

Comments are open to registered members. Log in or register to share your thoughts on this article.

Log in to comment Register for free